Description: Bcl-3 was first identified as a putative proto-oncogene and was originally isolated though its involvement in the translocation t(14;19). The Bcl-3 gene product is also thought to play a role in the immune system through its interactions with the NF-kappaB family of transcription factors, to enhance proliferation and to act as a transcription cofactor. More specifically, Bcl-3 appears to regulate the activity of homodimeric NF-kappaB p50 subunit and a closely-related homolog, p52, in a phosphorylation-dependent manner. Bcl-3 mRNA is found in a number of tissues, including spleen and other lymphoid tissues.
Primary Antibody
|
Name: Bcl-3 Oncoprotein Antibody |
|
Clone: 1E8, Mouse Anti-Human |
|
Supplier: Novocastra Labs |
|
Catalog Number: NCL-Bcl-3 |
|
Dilution: 1:100 using IHC-TekTM Antibody Diluent (Cat# IW-1000 or IW-1001) to reduce background and unspecific staining and serum blocking step is NOT needed. |
|
Incubation Time/Temp: 60min/room temperature |
| Device: IHC-TekTM Epitope Retrieval Steamer Set (Cat# IW-1102) |
| Buffer/pH value: IHC-TekTM Epitope Retrieval Solution (Cat# IW-1100) |
| Heat/Cool Temperature: 95-100 ºC/room temperature |
| Heat/Cool Time: 20 minutes/20 minutes |
| Standard Method: ABC Method or LSAB Method |
| Enhanced Method: Polymeric Methods |
| Reagent: DAB |
| Incubation Time/Temperature: 1-3 minutes/room temperature |
| Reagent: Gill's Hematoxylin or Mayer's Hematoxylin |
| Staining Time: 30 seconds |
| Staining Pattern: Nulcear |
| Images: Search image |
| Tissue Type: Tonsil |
| Fixation: Formalin-fixed paraffin sections, or acetone fixed frozen sections |
| Positive Control: Tonsil |
| Negative Control: Omit primary antibody, isotype control, absorption control |
| Blocking: 2-5% normal serum to reduce unspecific background staining; 0.5-3% H2O2 to block endogenous peroxidase activity; avidin/biotin to block endogenous biotin activity if necessary |
There is no need to perform antigen retrieval on acetone fixed frozen sections |
References: